Vikram Thermo (India) Ltd. (BSE: 530477) is a Ahmedabad, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹1,258 Cr, it ranks #1,464 by market cap among the 6,137 Indian listed companies on FinBizNet, and #45 of 86 in Medicinal Chemicals and Botanical Products. At ₹311.90 (as of 25 Oct 2026), the share price is 32.9% below its 52-week high of ₹464.70 and 134.2% above its 52-week low of ₹133.20. The share price is up 85.4% over one year and up 27.3% over three months.
| Current Price | ₹311.90 |
|---|---|
| Market Cap | ₹1,258 Cr |
| BSE Code | 530477 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 31 |
| Return on Equity | 7.17% |
| Return on Assets | 19.13% |
| 52-Week Range | ₹133.20 – ₹464.70 |
| 1-Year Price Change | +85.4% |
| 3-Month Price Change | +27.3% |
| Beta (1Y) | 0.36 |
| Dividend Yield | 0.33% |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.vikramthermo.com |
Vikram Thermo (India) Limited engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally. The company offers pharmaceutical polymer products, such as DRUGCOAT, a methacrylic co-polymer-based pharma polymer used for enteric and protective coating, taste masking, and sustained release formulation; DRCOAT, provides aqueous and non-aqueous based tablet coating system; and diphenyl oxide, an aromatic chemical. It also provides cosmetic polymers comprising AQUAPOL polymer, an acrylic acid polymer; and APION cross-linked polymers. The company was founded in 1985 and is based in Ahmedabad, India.
1. Manufacturing of Chemicals-This segment manufactures and markets pharmaceutical excipients and chemicals.
1. Pharma Polymers-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Vikram Thermo (India) Ltd. | ₹1,258 Cr | 31 | 7.17% | — | +85.4% |
Listed by market capitalisation. Ratios are shown for context only.
Vikram Thermo (India) Ltd. is trading at ₹311.90, with a market capitalisation of ₹1,258 Cr.
Vikram Thermo (India) Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Vikram Thermo (India) Ltd. has a P/E of 31 and a return on equity of 7.17%.
Vikram Thermo (India) Ltd. is listed on the BSE under the scrip code 530477.
Vikram Thermo (India) Ltd.'s share price is up 85.4% over one year and up 27.3% over three months. Its 52-week range is ₹133.20 to ₹464.70.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.